Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11883-022-01042-6.pdf
Reference17 articles.
1. Tita AT, Szychowski JM, Boggess K, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022. https://doi.org/10.1056/NEJMoa2201295. In a large, multicenter, diverse trial of 2,408 pregnant individuals with mild chronic hypertension randomized to a blood pressure goal <140/90 mmHg versus control, there was a reduction in the incidence of adverse pregnancy outcomes in the active treatment arm compared with usual care without impairing fetal growth or causing maternal or perinatal harm.
2. Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N Engl J Med. 2021;384:129–39. In a trial of 10,584 patients with T2DM and CKD randomized to either sotagliflozin or placebo, there was a significant reduction in the composite endpoint of cardiac death and hospitalizations/urgent care visits for heart failure. Benefits remained consistent regardless of baseline ejection fraction.
3. Lee MT, George J, Shahab H, Hermel M, Rana JS, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2022;24:61–72.
4. Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Curr Atheroscler Rep. 2021;23:76.
5. Jain V, Al Rifai M, Mahtta D, Liu J, Hussain A, Virani SS. Highlights from studies presented at the virtual american college of cardiology scientific sessions 2021: staying updated with the latest advancements in prevention. Curr Atheroscler Rep. 2021;23:50.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential Novel RNA-Targeting Agents for Effective Lipoprotein(a) Lowering: A Systematic Assessment of the Evidence From Completed and Ongoing Developmental Clinical Trials;Journal of Cardiovascular Pharmacology;2023-07
2. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference;Current Atherosclerosis Reports;2023-04-22
3. Deep and Transfer Learning based methods for Left Ventricle segmentation from cardiac MRI images to identify cardiovascular ailments;2023-04-06
4. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions;Current Atherosclerosis Reports;2023-01
5. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress;Current Atherosclerosis Reports;2022-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3